negative

Documents about negative

• Negative oder negative Anthropologie?#97182PhilArchive
• Reverse Triple Negative Immune Resistant Breast Cancer#325309ClinicalTrials.gov
• Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer#332737ClinicalTrials.gov
• Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer#387169ClinicalTrials.gov
• Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia#67921ClinicalTrials.gov
• MicroRNA Profiles in Triple Negative Breast Cancer#141066ClinicalTrials.gov
• Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer#245507ClinicalTrials.gov
• A Platform Trial for Gram Negative Bloodstream Infections#314374ClinicalTrials.gov
• Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy#234493ClinicalTrials.gov
• Nebulized Colistin for Gram Negative VAP Prevention.#28353ClinicalTrials.gov
• Antibiotic Durations for Gram-negative Bacteremia#136351ClinicalTrials.gov
• Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial#154711ClinicalTrials.gov
• Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy#123570ClinicalTrials.gov
• Efficacy of Interleukin-2 in Triple Negative Breast Cancer#307467ClinicalTrials.gov
• Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer#28435ClinicalTrials.gov
• QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine#387197ClinicalTrials.gov
• Triple-Negative Breast Cancer Versus Non-Triple-Negative Breast Cancer: The Impact of Pd and Pt Complexes on Basal-Like Triple-Negative Breast Cancer.#170565NCBI PubMed Central
• A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer#353297ClinicalTrials.gov
• Are mice a bad model for successive negative contrast?#227264Europe PMC
• Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit#238146ClinicalTrials.gov
• Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia#414512ClinicalTrials.gov
• Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria#474788ClinicalTrials.gov
• Load Minimization Triggers Quantum Consciousness — An LMT Extension of Orch-OR via Negative Time and Negative Entanglement —#171209PhilArchive
• Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients#287389ClinicalTrials.gov
• Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients#363638ClinicalTrials.gov
• Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer#366591ClinicalTrials.gov
• Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery#383568ClinicalTrials.gov
• TNBC Gut Microbiota During Neoadjuvant Treatment#405156ClinicalTrials.gov
• Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)#261467ClinicalTrials.gov
• Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy#234433ClinicalTrials.gov
• Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy#390915ClinicalTrials.gov
• Negative Ion Surface Production: a comparison between the C12A7 electride and gadolinium#370902HAL (France)
• Assessing Repetitive Negative Thinking Across the Adult Lifespan: Validation and Measurement Invariance of the Dutch Persistent and Intrusive Negative Thoughts Scale (PINTS)#439836OSF
• Predictors of Rates of Resistant Gram-Negative Bacteria#28358ClinicalTrials.gov
• "neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer#174862ClinicalTrials.gov
• Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals#184881ClinicalTrials.gov
• Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer#272340ClinicalTrials.gov
• Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer#321549ClinicalTrials.gov
• Making Sense of Negative Numbers#333788GUPEA
• Assessing Repetitive Negative Thinking Across the Adult Lifespan: Validation and Measurement Invariance of the Dutch Persistent and Intrusive Negative Thoughts Scale (PINTS)#16097OSF
• Buck-passers' negative thesis#87245PhilArchive
• Positive and Negative Facts#87833PhilArchive
• Essence of negative metaphysics#95672PhilArchive
• Factors Influencing Negative Behavior#97427PhilArchive
• Adorno's Negative Dialectics#115620PhilArchive
• 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)#18622ClinicalTrials.gov
• VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study#67874ClinicalTrials.gov
• Twinned-magnesium metal negative electrodes enable reversible magnesium electrodeposition#348163Materials Cloud Archive
• <Integrated Research Center for Carbon Negative Energy Science> Integrated Research Center for Carbon Negative Energy Science#351013Kyoto University Research Information Repository
• Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca#429760ClinicalTrials.gov